Food, Global Health 5 min

Food additive E551 could promote coeliac disease

PRESS RELEASE - A recent study has found that food additive E551, also known as silicon dioxide, can reduce oral tolerance to dietary proteins and could foster the development of coeliac disease. Born of a collaboration among researchers at INRAE and McMaster University in Canada, this pioneering work is the first to highlight the potential toxicity of E551, a nanometric ingredient that is added to a wide range of consumer food products. The results were published on 21 February in Environmental Health Perspectives.

Published on 21 February 2024

illustration Food additive E551 could promote coeliac disease
© AdobeStock

E551, more commonly known as silicon dioxide, is a powder composed of nanoparticles (i.e., particles < 100 nm in size). It serves as an anti-caking agent in an array of dry and powdered foods, including soups, spices, cereal-based infant formula, instant coffee, cocoa mix, and freeze-dried pasta. It can be found among the ingredients of over 2,600 processed foods worldwide1. It prevents the formation of lumps, thus preserving food taste, texture, and stability. Additionally, E551 is widely used as an essential processing aid in various food transformation processes. In such situations, it does not appear in the ingredients list on the packaging, even if it is present in the final product. Thus, we are exposed to low doses of E551 on a daily basis via the food we consume.

Researchers at INRAE and McMaster University in Canada combined their expertise to explore whether this level of exposure could affect the intestinal immune system. More specifically, they explored the impact on oral tolerance to dietary proteins. The latter is a crucial nutritional function, in which a tolerogenic response is induced in the intestine to block inflammatory immune reactions against the proteins we consume. This system is operational from birth. Any disruptions can lead to the development of food sensitivities, which can take the form of allergic reactions (e.g., to peanuts, cow's milk, fish, shellfish, eggs) or autoimmune conditions, such as coeliac disease.

Coeliac disease is a genetically linked autoimmune disorder that causes people to react to gluten, a protein in cereals such as wheat, rye, and barley. Symptoms include intestinal inflammation, abdominal pain, and diarrhoea. Those afflicted may experience severe weight loss and nutritional deficiencies. The prevalence of coeliac disease is on the rise globally, but the reasons for this trend are opaque. In this study, researchers exposed mice to E551 on a daily basis for 3 months. They observed that the animals demonstrated lower oral tolerance to dietary proteins and, in tandem, greater levels of intestinal inflammation. The researchers also examined the underlying mechanisms. They found that exposure to E551 reduced the number of intestinal immune cells responsible for producing the anti-inflammatory compounds needed to prevent gut reactivity. Using mice that express the coeliac disease risk gene, the researchers then discovered that daily exposure to E551 worsened levels of the inflammation markers associated with the disease.

Taken together, these results indicate that chronic exposure to E551 via dietary sources could promote the development of coeliac disease in people genetically predisposed to the condition.


This research2 is the first to underscore the potential toxicity of this food additive, which is currently considered to be safe for consumption. To help ensure that potential concerns about E551 are considered during human risk assessments, the researchers used exposure methodologies that fit with the expectations of European and North American food safety agencies (European Food Safety Authority, Health Canada). More specifically, they used human dosages, incorporated the additive into food, and conducted longer-term experiments.



2 This study was performed as part of the ANR-funded project PAIPITO (2017–2020), which looked at interactions among food compounds, inflammation, intestinal diseases, and oral tolerance. The team is continuing this line of inquiry via a number of projects, funded through 2027, with collaborators at the French National Laboratory for Metrology and Testing (LNE), CNRS, and INSERM.


Lamas B. et al. Evaluating the Effects of Chronic Oral Exposure to the Food Additive Silicon Dioxide on Oral Tolerance Induction and Food Sensitivities in Mice. Environmental Health Perspectives (2024) Volume 132, Issue 2 DOI : 10.1289/EHP12758

Learn more

Food, Global Health

New prospects for the treatment of gluten intolerance thanks to the intestinal microbiota

PRESS RELEASE - Celiac disease is an immune disease of the intestine that affects more than 1% of the population. It is characterised by gluten intolerance that causes inflammation of the gut, abdominal pain and diarrhoea, and can lead to weight loss and deficiencies among patients. An international research consortium involving teams from McMaster University (Canada), INRAE, Sorbonne University Paris, INSERM, Paris Public Hospitals (AP-HP) and Wageningen University (Netherlands) has shown that the intestinal microbiota of celiac patients displays a defect in the production of active compounds that result from the breakdown of tryptophan by microorganisms. Their findings, published on 21 October in Science Translational Medicine, show that a dietary intake of tryptophan or supplementation with probiotics that can metabolise this amino acid diminish the intestinal lesions of celiac disease in animals and offer new therapeutic prospects in humans.

22 October 2020

Food, Global Health

Titanium dioxide: E171 first enters the blood via the mouth

PRESSE RELEASE - The use of E171 in food has been banned in Europe since 2022. Pioneering work by INRAE has shown that this food additive passes into the bloodstream and has toxic effects in the intestine. In recent work, INRAE researchers, in collaboration with the LNE, have taken their analysis a step further. The results, published on 17 May in Nanotoxicology, show that the nanoparticles that make up this additive can pass directly through the buccal mucosa.

16 May 2023

Food, Global Health

Nanoparticles of titanium dioxide: E171 crosses the placental barrier

PRESS RELEASE - What is titanium dioxide? It is an important food additive widely used throughout the world for its opacifying and colouring properties (white pigment). Better known in Europe as E171, the sale of food products containing this additive has been suspended in France since January 1st, 2020, for precautionary reasons[1]. Studies[2] by INRAE scientists in 2017 had provided the scientific proof necessary to underpin this limited measure, introduced for a period of one year potentially renewable. Working in collaboration with the Laboratoire national de métrologie et d’éssais (LNE), the Groupe de Physique des Matériaux (CNRS/INSA Rouen/Université de Rouen-Normandie), Toulouse University Hospital, Picardie-Jules Verne University and the National Veterinary School in Toulouse, the same scientists continued their work in humans and now supplied proof that the titanium dioxide nanoparticles present in E171 can cross the placenta and reach the foetal environment. Their results, published on October 7th in Particle and Fibre Toxicology, alert on the importance of evaluating the risk of exposure of pregnant women to these nanoparticles.

05 October 2020